|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR DRUG-INDUCED RENAL TOXICITY
|
ZIDOVUDINE HEMATOLOGIC TOXICITY IS INCREASED BY THE CYTOTOXIC DRUGS
|
5-AMINO SALICYLIC ACID INHIBITS THE METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
POTENTIAL FOR RARE LIFE-THERATENING HEPATIC VENO-OCCLUSIVE DISEASE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEUROTOXICITY
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
MAY HAVE ADDITIVE EFFECT ON THE NEPHROTOXICITY OF ASPIRIN
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|